Skip to content
Aperlena
Language:

Germany - Medicines - Open House Biosimilar Discount Contracts 2026-23 - Darbepoetin alfa

Original Deutschland - Arzneimittel - Open House Biologika Rabattverträge 2026-23 - Darbepoetin alfa

Open Contract notice 673 days left
Watch this tender

Deadline 31 Jul. If it moves, an email when the register sees it. A correction: the same email. Your plan: decide by 17 Jul, questions by 17 Jul, draft by 24 Jul. Log in

  1. Published
  2. Today
  3. Deadline open for 787 days
  4. Awarded pending

Summary

Machine-generated summary

TK (Techniker Krankenkasse), a German statutory health insurer, intends to conclude rebate contracts under Section 130a(8) SGB V for the active substance darbepoetin alfa. Several lots are formed for different dosage strengths. The procedure is an open house process: identical conditions apply to all participants and no individual negotiations on contract terms are conducted. TK does not guarantee exclusivity to any contracting partner. Suitable pharmaceutical entrepreneurs may participate. Contracts run for a maximum of 24 months starting on 01.08.2026 and end at the latest on 31.07.2028, regardless of the date of conclusion.

Description

Die TK verfolgt das Ziel, mit allen geeigneten pharmazeutischen Unternehmern Rabattverträge nach § 130a Abs. 8 SGB V zu dem Wirkstoff Darbepoetin alfa (es werden mehrere Lose zu unterschiedlichen Wirkstärken gebildet, siehe Angaben bei den jeweiligen Losen) zu schließen. Der Vertragsschluss erfolgt im Rahmen des Open-House-Verfahrens der TK: Individuelle Verhandlungen über Vertragsinhalte werden nicht geführt, es gelten einheitliche Konditionen. Die TK sichert einzelnen Vertragspartnern keine Exklusivität zu. Die Vertragslaufzeit beträgt maximal 24 Monate beginnend mit dem 01.08.2026. Der Vertrag endet spätestens am 31.07.2028, unabhängig vom Datum des Vertragsschlusses. Alle weiteren Informationen sind den Teilnahme- und Vertragsunterlagen zu entnehmen. Die TK verfolgt das Ziel, mit allen geeigneten pharmazeutischen Unternehmern Rabattverträge nach § 130a Abs. 8 SGB V zu dem Wirkstoff Darbepoetin alfa zu schließen.

Official source

Source: TED - Tenders Electronic Daily (Publications Office of the EU)

Always verify details on the official notice.

Last verified against TED - Tenders Electronic Daily (Publications Office of the EU) 1 month ago

View the official notice

More from this buyer

Full buyer profile

52 open tenders right now

This buyer has no award history in this sector yet. Usual winners, Medical equipment & pharmaceuticals - Germany

Company Wins Total awarded Last win
Siemens Healthineers AG 42 €17.4M Sep 2026
Philips GmbH 20 €5.3M Sep 2026
GlaxoSmithKline GmbH & Co. KG 15 n/a Sep 2026
ASTRAZENECA GMBH 12 n/a Jul 2026
Brainlab Sales GmbH 10 €4.0M Sep 2026

Based on 1018 awards with a linked company profile over the last 2 years.

Change history

Every time an official source republished this notice with different content. We watch every source we index, including regional copies of the same notice.

  1. Act now
    • Submission deadline: Moved 1 day EARLIER: now July 31, 2028, 00:00
    • Scope and criteria: The description was expanded. Re-read it before you bid.

Follow this tender and we email you the moment it changes. Create account

Similar tenders

Market context

Avg. open tender · Medical equipment & pharmaceuticals
€10,066,160
9,838 open across Europe right now
Buyer track record on Aperlena
55 notices tracked · 0 awarded

Never miss a tender like this

76 new notices in Medical equipment & pharmaceuticals in Germany in the last 7 days. Get an email when new ones appear. Free.

Set up my alert

673 days left

Source

Keyboard shortcuts

Read a list without reaching for the mouse. The shortcuts stay quiet while you type in a field.

j
Next result
k
Previous result
Enter
Open the result
n
Next page
p
Previous page
c
Compare this result
s
Shortlist this result
/
Jump to the search box
?
Show these shortcuts
Esc
Close